Insider Trading History of Poma Eric E

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Poma Eric E since 2018. This trader's CIK number is 1339484. At the time of last reporting, Poma Eric E was the Chief Executive Officer of Calidi Biotherapeutics, Inc.. (stock ticker symbol CLDI). Also see all insider trading activities at Calidi Biotherapeutics, Inc..

Note that in the past Poma Eric E also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Molecular Templates, Inc. (MTEM) by Poma Eric E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 MTEM 0 $0 0 $0 34,156 $24,250
2021 MTEM 0 $0 0 $0 3,563 $2,529
2018 MTEM 0 $0 0 $0 239,896 $135,541

Yearly summary of insider trading at Calidi Biotherapeutics, Inc. (CLDI) by Poma Eric E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 CLDI 25,000 $50,000 0 $0 0 $0


Insider trading activities at 2 companies by Poma Eric E:

1. Molecular Templates, Inc. (MTEM)

2. Calidi Biotherapeutics, Inc. (CLDI)

Table 1. Insider trading of Molecular Templates, Inc. (MTEM) by Poma Eric E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-04-27 MTEM Option Ex 34,156 .71 24,250
2021-07-06 MTEM Option Ex 3,563 .71 2,529
2018-11-26 MTEM Option Ex 239,896 .56 135,541

Table 2. Insider trading of Calidi Biotherapeutics, Inc. (CLDI) by Poma Eric E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-21 CLDI Buy 25,000 2.00 50,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Poma Eric E (Chief Executive Officer of Calidi Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.